Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

Summary of Changes in Nonvested Restricted Stock Awards

A summary of changes in our nonvested shares for the year follows:

				Weighted
				Average
				Grant-Date
(shares in thousands)	Shares			Fair Value
Year Ended December 31, 2019
Nonvested balance at beginning of period		419		$	16.77
Granted during the year		214			16.50
Vested during the year		(201	)		16.00
Forfeited during the year		(26	)		17.19
Nonvested balance at end of period		406		$	16.98

Summary of Changes in Nonvested Restricted Shares

A summary of changes in our nonvested shares for the year follows:

				Weighted
				Average
				Grant-Date
(shares in thousands)	Shares			Fair Value
Year Ended December 31, 2019
Nonvested balance at beginning of period		893		$	13.31
Granted during the year		375			12.67
Vested during the year		(308	)		10.17
Forfeited during the year		(27	)		13.61
Dividend equivalents adjustment		32			13.85
Nonvested balance at end of period		965		$	14.07

Summary of Activity in Stock Option Plan

A summary of the activity in the stock option plan in 2019 follows:

						Weighted
				Weighted		Average		Aggregate
				Average		Remaining		Intrinsic
				Exercise		Contractual		Value
(shares in thousands)	Shares			Price		Term in Years		(in thousands)
Year Ended December 31, 2019
Outstanding at beginning of period		92		$	6.30
Exercised		(29	)		10.44
Forfeited/expired		(6	)		7.73
Outstanding at end of period		57		$	4.11		2.02	$	814.2
Options exercisable at end of year		57		$	4.11		2.02	$	814.2

Schedule of Information Related to Stock Option Plan

At December 31, 2019, the outstanding shares consisted of stock appreciation rights acquired through prior year acquisitions.

Information related to the stock option plan during each year follows:

	Years Ended December 31,
(dollars in thousands)	2019		2018		2017
Intrinsic value of options exercised	$	178	$	385	$	806
Cash received from option exercises		280		948		2,655
Tax benefit realized from option exercises		71		154		318